Optimized Whole-Body PET MRI Sequence Workflow in Pediatric Hodgkin Lymphoma Patients-Reference-Cited by-同舟云学术

Optimized Whole-Body PET MRI Sequence Workflow in Pediatric Hodgkin Lymphoma Patients

Published:2022-07-14 Issue:1 Volume:64 Page:96-101
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Georgi Thomas W.,Stoevesandt Dietrich,Kurch Lars,Bartelt Jörg M.,Hasenclever Dirk,Dittmann Helmut,Ferda Jiri,Francis Peter,Franzius Christiane,Furth Christian,Gräfe Daniel,Gussew Alexander,Hüllner Martin,Menezes Leon J.,Mustafa Mona,Stegger Lars,Umutlu Lale,Zöphel Klaus,Zucchetta Pietro,Körholz Dieter,Sabri Osama,Mauz-Körholz Christine,Kluge Regine

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference42 articles.

1. 18F-FDG PET/MRI for staging and interim response assessment in pediatric and adolescent Hodgkin lymphoma: a prospective study with 18F-FDG PET/CT as the reference standard;Verhagen;J Nucl Med.,2021

2. Diagnostic performance of FDG-PET/MRI and WB-DW-MRI in the evaluation of lymphoma: a prospective comparison to standard FDG-PET/CT;Herrmann;BMC Cancer.,2015

3. 18F-FDG-PET/MRI in lymphoma patients;Ferdová;Eur J Radiol.,2017

4. Whole-Body PET/CT Scanning: Estimation of Radiation Dose and Cancer Risk

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hodgkin lymphoma involving the extra-axial CNS: an AHOD1331, PHL-C1, and PHL-C2 report from the COG and EuroNet-PHL;Blood Advances;2024-09-24

2. Current Applications of PET/MR: Part II: Clinical Applications II;Canadian Association of Radiologists Journal;2024-06-05

3. Kommentar zu „KINDER – Lymphomstaging und -restaging mit der kontrastmittelfreien FDG-PET/MRT“;RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren;2024-04-25

4. Update on FDG-PET in pediatric lymphoma;The Quarterly Journal of Nuclear Medicine and Molecular Imaging;2024-04

5. HYBRID – Optimierte Ganzkörper-PET/MRT für Kinder mit Hodgkin-Lymphom;Angewandte Nuklearmedizin;2024-03